Delivering commercial value
through innovation in
cleantech sectors

Our Team

Michael Ellis

Michael has particular expertise in industry analysis, business planning and intellectual property. His focus is on technology-driven businesses, including renewable energy technology, materials, chemistry, pharmaceuticals and medical devices.

Michael’s recent assignments include: proposing and implementing IP protection strategies for a number of SMEs in the field of renewable energy, including tidal, offshore wind, solar, and fuel management technologies; conducting a freedom to operate review for a drug delivery technology as part of investment due diligence; conducting market and industry analyses and proposing an optimum business model for an Imperial College spinout with a drug structure prediction capability; providing patent infringement and validity advice for Imperial Innovations; and, with Orion Innovations, examining the wind turbine industry to develop a framework of key business factors to be employed in emergent renewable energy businesses. 

During his MBA, Michael was a finalist in the Imperial College Business Plan Competition and the Research Council UK Business Plan Competition with a plan to commercialise an oxygen therapy device developed by an Imperial PhD student.

Previously, as an in-house patent attorney for Kodak, Michael handled European prosecution of Kodak’s ink jet media patent portfolio, consulted on portfolio management and provided design and patent clearance opinions for new products. He also successfully led a team in patent opposition proceedings before the EPO for a key Kodak product.

Prior to joining Kodak, Michael spent four years with Beck Greener, a London firm of patent attorneys, where he consulted on strategies for negotiating intellectual property and licence terms to enable global licensing of pharmaceutical products, and guided client companies and inventors in pursuing patent protection for pharmaceutical, medical device, polymer, catalyst and engineering solutions.

Michael has a PhD in Pharmaceutical Sciences from the University of Nottingham.

< Back

Our Clients